
Xu Qing
Yuanhe chenkun gives full play to the value discovery function of the master fund, explores, supports and accompanies excellent fund management team, and realizes industrial support and investment demand. Relying on in-depth understanding and judgment of the industry, Yuanhe chenkun focuses on the long-term development dividend of medical and health, as well as the industrial upgrading and innovation opportunities driven by intelligence and digitization.
By virtue of the master fund's portfolio allocation ability and its own scale effect, yuanhechengkun accurately grasps the demands of capital and resource sides, continues to play the pivotal role of industrial development and resource convergence, provides good opportunities for resource sides to participate in China's scientific and technological innovation development, and promotes the development of real economy with the rapid growth of emerging industries.
Ms. Xu Qing is now the managing partner of Yuanhe chenkun.
Since 2006, Ms. Xu Qing has led the Yuanhe chenkun team to lead the establishment, investment, management and exit of the four master funds. He has served as a member of the Advisory Committee of dozens of funds such as Qiming, Zhongding, Tonghe, Yuanjing, Songhe, Softbank China and Lilly.
Ms. Xu Qing has more than 20 years of investment management experience in large venture capital institutions, and is familiar with China's venture capital market and fund investment operation
Ms. Xu Qing holds a master's degree in management from Xi'an Jiaotong University and a bachelor's degree in law from Fudan University.
Related Teams

Inquiry: fof@oriza.com
Join Us: hr@oriza.com
Suzhou: +86-0512-66969722
Beijing: +86-010-65000132

Scan QR code
Copyright © Oriza FOFs All rights reserved 京ICP备16013165号-1 Powered by 300.cn